Long-term Results of Surgery for Liver Hemangiomas

医学 剜除术 外科 肝血管瘤 择期手术 剖腹手术 病变 回顾性队列研究 腹痛 病态的 血管瘤 病理
作者
İlgin Özden,A. Emre,Aydın Alper,Mehtap Tunacı,K Acarli,O Bilge,Yaman Tekant,O Arioğul
出处
期刊:Archives of Surgery [American Medical Association]
卷期号:135 (8): 978-978 被引量:84
标识
DOI:10.1001/archsurg.135.8.978
摘要

Elective surgery for liver hemangiomas is still controversial.Long-term results show that elective surgery for liver hemangiomas is safe and effective.A tertiary care university hospital in Istanbul, Turkey.Forty-two patients underwent surgery for liver hemangiomas between January 1988 and December 1998; 41 were symptomatic. The primary indications for surgery were abdominal pain in 33 patients, diagnostic uncertainty in 6, and enlargement in 3. The median largest dimension of the major lesion was 10 cm (range, 7-45 cm).(1) Patients' assessment of the effects of surgery on preoperative symptoms, (2) determination of whether any other pathological conditions were missed in the preoperative evaluation, (3) operative mortality and morbidity, and (4) recurrences.Retrospective cohort study.Enucleation was the most frequent operation (33 patients). Hospital mortality and morbidity were 2.4% (bleeding from the biopsy site on a lesion evaluated as inoperable at laparotomy; 1 patient) and 12% (5 patients), respectively. Thirty-three patients could be followed up for a median of 53 months (range, 6-135 months). Of the 32 preoperatively symptomatic patients, surgery was successful in symptom control in 28 (88%) (complete resolution or significant amelioration). No other cause of pain could be identified during follow-up in the other patients. Control ultrasonography revealed no recurrences.Elective surgery is indicated in a small subset of patients with hemangiomas because of abdominal pain, enlargement, and diagnostic uncertainty. The results of surgery in symptom control are gratifying in approximately 90% of patients. Recurrences are rare. Enucleation can be performed rapidly and safely in most patients and should be preferred to resection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5114完成签到,获得积分10
刚刚
渡星河完成签到,获得积分10
1秒前
研友_ZA2B68完成签到,获得积分0
1秒前
兜兜揣满糖完成签到 ,获得积分10
2秒前
阳光的幻雪完成签到 ,获得积分10
3秒前
JJJ完成签到,获得积分10
4秒前
饱满绮波完成签到 ,获得积分10
5秒前
文心同学完成签到,获得积分0
5秒前
339564965完成签到,获得积分10
7秒前
hmv发布了新的文献求助10
9秒前
ccc完成签到,获得积分10
9秒前
健脊护柱完成签到 ,获得积分10
10秒前
Helios完成签到,获得积分10
12秒前
只想顺利毕业的科研狗完成签到,获得积分10
13秒前
ZHQ完成签到,获得积分10
13秒前
风信子完成签到,获得积分10
14秒前
xueshidaheng完成签到,获得积分0
14秒前
Brief完成签到,获得积分0
16秒前
nanostu完成签到,获得积分10
16秒前
吐司炸弹完成签到,获得积分10
17秒前
mayfly完成签到,获得积分10
17秒前
bkagyin应助科研通管家采纳,获得10
17秒前
科研通AI5应助科研通管家采纳,获得10
17秒前
仰望星空应助科研通管家采纳,获得10
17秒前
仰望星空应助科研通管家采纳,获得10
17秒前
布吉岛呀完成签到 ,获得积分10
18秒前
鹏举瞰冷雨完成签到,获得积分10
18秒前
Noshore完成签到,获得积分10
18秒前
悟空完成签到 ,获得积分10
20秒前
馆长应助拉长的诗蕊采纳,获得100
20秒前
21秒前
舒适涵山完成签到,获得积分10
22秒前
朱科源啊源完成签到 ,获得积分10
26秒前
Jun发布了新的文献求助10
26秒前
七街完成签到 ,获得积分10
26秒前
越野蟹完成签到,获得积分10
27秒前
科研通AI6应助liu采纳,获得30
27秒前
CikY完成签到 ,获得积分10
29秒前
方圆完成签到 ,获得积分10
30秒前
唐泽雪穗应助venihall采纳,获得10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
求中国石油大学(北京)图书馆的硕士论文,作者董晨,十年前搞太赫兹的 500
Vertebrate Palaeontology, 5th Edition 500
Narrative Method and Narrative form in Masaccio's Tribute Money 500
Aircraft Engine Design, Third Edition 500
Neonatal and Pediatric ECMO Simulation Scenarios 500
苏州地下水中新污染物及其转化产物的非靶向筛查 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4774488
求助须知:如何正确求助?哪些是违规求助? 4107380
关于积分的说明 12704943
捐赠科研通 3828286
什么是DOI,文献DOI怎么找? 2111991
邀请新用户注册赠送积分活动 1135950
关于科研通互助平台的介绍 1019462